|
Cardiovascular Pharmacology
Citations 141-150 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Preventive Cardiology
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis
- Scott D. Solomon, Janet Wittes, Peter V. Finn, Robert Fowler, Jaye Viner, Monica M. Bertagnolli, Nadir Arber, Bernard Levin, Curtis L. Meinert, Barbara Martin, Joseph L. Pater, Paul E. Goss, Peter Lance, Stefanie Obara, Emily Y. Chew, Jonghyeon Kim, Gretchen Arndt, Ernest Hawk for the Cross Trial Safety Assessment Group
Circulation 2008;117:2104-2113; published online before print as doi:10.1161/CIRCULATIONAHA.108.764530
[Abstract]
[Full text]
- New Drugs and Technologies
Therapeutic Uses of Inorganic Nitrite and Nitrate: From the Past to the Future
- Anthony R. Butler and Martin Feelisch
Circulation 2008;117:2151-2159, doi:10.1161/CIRCULATIONAHA.107.753814
[Abstract]
[Full text]
- Articles
Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs. A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing
- Victoria L. Vetter, Josephine Elia, Christopher Erickson, Stuart Berger, Nathan Blum, Karen Uzark, and Catherine L. Webb
Circulation published April 21, 2008, doi:10.1161/CIRCULATIONAHA.107.189473
[Abstract]
- Resuscitation Science
Left Ventricular Systolic Function and Outcome After In-Hospital Cardiac Arrest
- Maria M. Gonzalez, Robert A. Berg, Vinay M. Nadkarni, Caio B. Vianna, Karl B. Kern, Sergio Timerman, and Jose A. Ramires
Circulation 2008;117:1864-1872; published online before print as doi:10.1161/CIRCULATIONAHA.107.740167
[Abstract]
[Full text]
- Articles
Left Ventricular Systolic Function and Outcome After In-Hospital Cardiac Arrest
- Maria M. Gonzalez, Robert A. Berg, Vinay M. Nadkarni, Caio B. Vianna, Karl B. Kern, Sergio Timerman, and Jose A. Ramires
Circulation published March 31, 2008, doi:10.1161/CIRCULATIONAHA.107.740167
[Abstract]
- Articles
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials. The Cross Trial Safety Analysis
- Scott D. Solomon, Janet Wittes, Peter V. Finn, Robert Fowler, Jaye Viner, Monica M. Bertagnolli, Nadir Arber, Bernard Levin, Curtis L. Meinert, Barbara Martin, Joseph L. Pater, Paul E. Goss, Peter Lance, Stefanie Obara, Emily Y. Chew, Jonghyeon Kim, Gretchen Arndt, Ernest Hawk for the Cross Trial Safety Assessment Group
Circulation published March 31, 2008, doi:10.1161/CIRCULATIONAHA.108.764530
[Abstract]
- Genetics
Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
- Ronald M. Krauss, Lara M. Mangravite, Joshua D. Smith, Marisa W. Medina, Dai Wang, Xiuqing Guo, Mark J. Rieder, Joel A. Simon, Steven B. Hulley, David Waters, Mohammed Saad, Paul T. Williams, Kent D. Taylor, Huiying Yang, Deborah A. Nickerson, and Jerome I. Rotter
Circulation 2008;117:1537-1544; published online before print as doi:10.1161/CIRCULATIONAHA.107.708388
[Abstract]
[Full text]
- Correspondence
Response to Letter Regarding Article, "Bypassing Big Pharma"
- James M. Downey and Michael V. Cohen
Circulation 2008;117:e195, doi:10.1161/CIRCULATIONAHA.107.756403
[Full text]
- Vascular Medicine
Genetic and Pharmacological Targeting of Phosphoinositide 3-Kinase- Reduces Atherosclerosis and Favors Plaque Stability by Modulating Inflammatory Processes
- Anne Fougerat, Stéphanie Gayral, Pierre Gourdy, Alexia Schambourg, Thomas Rückle, Matthias K. Schwarz, Christian Rommel, Emilio Hirsch, Jean-François Arnal, Jean-Pierre Salles, Bertrand Perret, Monique Breton-Douillon, Matthias P. Wymann, and Muriel Laffargue
Circulation 2008;117:1310-1317; published online before print as doi:10.1161/CIRCULATIONAHA.107.720466
[Abstract]
[Full text]
- Articles
Variation in the 3-Hydroxyl-3-Methylglutaryl-Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
- Ronald M. Krauss, Lara M. Mangravite, Joshua D. Smith, Marisa W. Medina, Dai Wang, Xiuqing Guo, Mark J. Rieder, Joel A. Simon, Steven B. Hulley, David Waters, Mohammed Saad, Paul T. Williams, Kent D. Taylor, Huiying Yang, Deborah A. Nickerson, and Jerome I. Rotter
Circulation published March 10, 2008, doi:10.1161/CIRCULATIONAHA.107.708388
[Abstract]
|
|
